Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Shares of major U.S. health insurers have taken a significant hit as the final 2025 Medicare Advantage plan payment rates fall short of industry expectations, raising concerns about margins.

In a significant turn of events that caught the healthcare sector by surprise, shares of prominent U.S. health insurers experienced a sharp decline, tumbling between 6% to 12% this past Tuesday. This market response came in the wake of the government's final decision on the 2025 rates for Medicare Advantage (MA) payments, revealing a modest base rate cut.
The healthcare sector was the main detractor within the S&P 500 index, with a loss of 3.07% for the week. Healthcare ETFs plunged by 3.18% over the week, bringing their year-to-date performance to +4.06%. Those funds also witnessed significant outflows of $445 million this week.
Access Trackinsight's reliable and comprehensive data with 500M+ points on 14,000+ ETFs.
The finalized rates indicated a modest decrease of 0.2% in average payments for Medicare Advantage plans. This decision remained unchanged from the initial proposal made in January, despite considerable lobbying from healthcare companies.
This rather unexpected announcement has raised concerns about potential margin squeezes for insurers, particularly those already dealing with elevated medical costs. The situation is further compounded by ongoing uncertainties around insurance claims processing. Notably, the fallout from a hacking incident at UnitedHealth's tech unit has added another layer of complexity, disrupting normal operations and financial forecasts for insurers.
Humana, the second largest provider of MA plans in the U.S., witnessed its shares plummet over 9.5% for the week, falling to a four-year low below $300 before bouncing back to $313.11 at the close of Friday. Similarly, UnitedHealth experienced a 7.96% drop, followed by a 6.49% decrease in shares of CVS Health. Analysts, including BoFA Securities' Kevin Fischbeck, have pointed out that the combination of elevated costs and lower payment rates put substantial pressure on insurers. There's a growing concern that companies might have to reduce the range of benefits they offer, further affecting their competitive edge and bottom line.
The Health Care Select Sector SPDR Fund (
Please note this article is for information purposes only and does not in any way constitute investment advice. It is essential that you seek advice from a registered financial professional prior to making any investment decision.
Latest ETF News
See all ETF newsMoneyShow Chart of the Day 3/9/2026: Tallying Up the Costs in Oil Markets


MoneyShow Chart of the Day 2/11/2026: Why THIS Indicator Could be a Key Tech Tell


MoneyShow Chart of the Day 2/2/2026: The Wildest Week in Metals Ever?


MoneyShow Chart of the Day 1/28/2026: The Greenback is on the Brink...Again


Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Asset TV
The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring
Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.

What’sTheFund
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).

What’sTheFund
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).

What’sTheFund
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
